HomeCompareLVTTF vs VIG

LVTTF vs VIG: Dividend Comparison 2026

LVTTF yields 74074.07% · VIG yields 1.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LVTTF wins by $2.415744206754136e+25M in total portfolio value
10 years
LVTTF
LVTTF
● Live price
74074.07%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.415744206754136e+25M
Annual income
$24,093,458,170,968,554,000,000,000,000,000.00
Full LVTTF calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →

Portfolio growth — LVTTF vs VIG

📍 LVTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLVTTFVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LVTTF + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LVTTF pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LVTTF
Annual income on $10K today (after 15% tax)
$6,296,296.30/yr
After 10yr DRIP, annual income (after tax)
$20,479,439,445,323,270,000,000,000,000,000.00/yr
VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
At 15% tax rate, LVTTF beats the other by $20,479,439,445,323,270,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LVTTF + VIG for your $10,000?

LVTTF: 50%VIG: 50%
100% VIG50/50100% LVTTF
Portfolio after 10yr
$1.207872103377068e+25M
Annual income
$12,046,729,085,484,277,000,000,000,000,000.00/yr
Blended yield
99.74%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LVTTF buys
0
VIG buys
0
No recent congressional trades found for LVTTF or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLVTTFVIG
Forward yield74074.07%1.64%
Annual dividend / share$2.00$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2.415744206754136e+25M$32.4K
Annual income after 10y$24,093,458,170,968,554,000,000,000,000,000.00$179.15
Total dividends collected$2.415324649887447e+25M$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: LVTTF vs VIG ($10,000, DRIP)

YearLVTTF PortfolioLVTTF Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$7,418,107$7,407,407.41$11,304$163.92+$7.41MLVTTF
2$5,143,352,679$5,135,415,304.54$12,759$166.33+$5143.34MLVTTF
3$3,333,209,626,932$3,327,706,239,565.15$14,382$168.52+$3333209.61MLVTTF
4$2,019,042,046,668,882$2,015,475,512,368,064.00$16,192$170.52+$2019042046.65MLVTTF
5$1,143,136,308,564,991,200$1,140,975,933,575,055,600.00$18,210$172.34+$1143136308564.97MLVTTF
6$604,956,777,533,732,400,000$603,733,621,683,567,900,000.00$20,460$173.98+$604956777533732.38MLVTTF
7$299,246,003,348,033,900,000,000$298,598,699,596,072,800,000,000.00$22,968$175.48+$299246003348033920.00MLVTTF
8$138,361,209,034,681,260,000,000,000$138,041,015,811,098,890,000,000,000.00$25,763$176.83+$138361209034681270272.00MLVTTF
9$59,798,034,180,193,710,000,000,000,000$59,649,987,686,526,590,000,000,000,000.00$28,878$178.05+$5.979803418019371e+22MLVTTF
10$24,157,442,067,541,360,000,000,000,000,000$24,093,458,170,968,554,000,000,000,000,000.00$32,350$179.15+$2.415744206754136e+25MLVTTF

LVTTF vs VIG: Complete Analysis 2026

LVTTFStock

Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions. The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.

Full LVTTF Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this LVTTF vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LVTTF vs SCHDLVTTF vs JEPILVTTF vs OLVTTF vs KOLVTTF vs MAINLVTTF vs DGROLVTTF vs NOBLLVTTF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.